Onward Medical NV

ONWD
4,87
0,12 (2,53%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
03/5/202403:31GLOBEAvis de convocation à l’assemblée générale 2024 des..
02/5/202407:00GLOBEONWARD® Medical Convocation of the 2024 Annual General..
26/4/202415:17GLOBEONWARD® Medical annonce ses résultats financiers et..
25/4/202407:30GLOBEONWARD® Medical Reports Full Year 2023 Financial and..
11/4/202407:30GLOBEONWARD® Medical Announces Publication of Full Year 2023..
09/4/202407:00GLOBEStifel Initiates Research Coverage of ONWARD® Medical with a..
02/4/202407:30GLOBEONWARD® Medical Submits De Novo Application to FDA for its..
25/3/202417:40GLOBEONWARD® Medical Publishes Closing of Accelerated Bookbuild..
21/3/202418:26GLOBEONWARD® Medical Publishes Prospectus for Listing of New..
21/3/202403:03GLOBEONWARD® Medical Lève avec Succès 20 millions d'euros dans le..
20/3/202418:29UKREGONWARD® Medical Launches Capital Increase by Way of an..
20/3/202418:29GLOBEONWARD® Medical Launches Capital Increase by Way of an..
20/3/202418:24UKREGONWARD® Medical Lance une Augmentation de Capital par le..
20/3/202418:24GLOBEONWARD® Medical Launches Capital Increase by Way of an..
20/3/202418:24UKREGONWARD® Medical Launches Capital Increase by Way of an..
18/3/202407:30GLOBEONWARD® Medical Successfully Completes Benchmark Testing on..
15/3/202407:30GLOBEONWARD renforce son management avec des nominations clés..
11/3/202407:30GLOBEONWARD® Medical Accepted to New US FDA TAP Program for..
29/2/202407:41GLOBEONWARD® Medical Awarded 10th Breakthrough Device Designation..
09/2/202407:30GLOBEKBC Securities Initiates Research Coverage of ONWARD®..
07/2/202421:55GLOBEONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE
25/1/202423:11GLOBEONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of..
22/1/202420:03GLOBEONWARD® to Participate in Basel Healthtech Conference 2024
19/1/202418:48GLOBEONWARD® to Participate in Degroof Petercam Healthcare..
18/1/202407:30GLOBEONWARD® Announces Start of HemON NL Clinical Study
16/11/202307:30GLOBEONWARD renforce son management avec des nominations clés..
06/11/202318:13GLOBEONWARD verstärkt Führungsteam auf Schlüsselpositionen in den..
11/10/202319:43GLOBEONWARD Schedules Webcast to Provide Third Quarter 2023..
27/9/202307:30GLOBEONWARD® Announces First-in-Human Implant of ARC-IM™..
19/9/202306:30GLOBEONWARD® publie ses résultats semestriels 2023 et fait le..
13/9/202318:40GLOBEONWARD® lance un partenariat avec une entreprise appartenant..
06/9/202302:23GLOBEONWARD prévoit une webdiffusion pour fournir une mise à jour..
24/5/202317:30GLOBEBrain Computer Interface (BCI) Enables Thought-Controlled..
16/5/202307:30GLOBEONWARD Reports Q1 Business Update and Year-To-Date..
15/5/202317:30GLOBEONWARD gibt erstmalige Anwendung der ARC-IM™-Elektrode zur..
08/5/202315:57GLOBEONWARD Announces Results of Annual General Meeting of..
Apertura: 4,84 Min: 4,76 Max: 4,89
Chiusura: 4,75

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network